UBE2I Gene

HGNC Family Ubiquitin-conjugating enzymes E2 (UBE2)
Name ubiquitin-conjugating enzyme E2I
Description The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. Four alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nUBE2I, which encodes the sole SUMO‐conjugating enzyme Ubc9, is central to the post‐translational modification process called SUMOylation. Through a conserved mechanism akin to ubiquitination, Ubc9 transfers the small ubiquitin‐like modifier (SUMO) onto specific lysine residues of a wide variety of substrate proteins. This modification alters targets’ activity, stability, subcellular localization, or protein–protein interactions and is essential for a spectrum of cellular functions including regulation of nuclear transport, transcriptional control, apoptosis, and responses to cellular stress. Structural and biochemical studies have revealed that Ubc9 binds directly to SUMO proteins and interacts with multiple E3 ligases—such as Nup358/RanBP2—to optimally position its thioester‐linked SUMO for efficient conjugation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond acting as a mere “SUMO donor,” UBE2I/Ubc9 is subject to multiple levels of regulation that fine‐tune SUMO conjugation. Its substrate discrimination can be modulated through auto‐modification events—for example, autoSUMOylation of Ubc9 alters its ability to engage distinct targets—and by its association with accessory proteins such as RSUME, which enhances SUMO binding and thioester formation. In addition, post‐translational modifications of Ubc9 (including phosphorylation, acetylation, and redox‐dependent modifications) regulate interactions with transcriptional regulators and nuclear receptors (for instance, affecting factors such as Elk-1, COUP-TF, and the mineralocorticoid receptor), thereby influencing nuclear retention, transcriptional output, and protein stability."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAberrant regulation of UBE2I/Ubc9 has been implicated in a variety of pathological conditions. Elevated expression and altered activity of Ubc9 have been observed in cancers of the breast, ovary, lung, melanoma, and glioma where they correlate with aggressive tumor behavior, chemoresistance, apoptosis evasion, and enhanced metastasis. In parallel, several oncogenic viruses (including human papillomavirus, Epstein–Barr virus, SARS-CoV, and adenovirus) exploit Ubc9 to reprogram host SUMOylation, thereby modulating the stability and function of both viral and cellular proteins. Emerging data also link Ubc9 function to KRAS-driven transformation and even to metabolic adaptations such as adipocyte browning. Collectively, these studies indicate that defects in UBE2I-driven SUMOylation contribute to tumor progression, virus-induced cellular transformation, and resistance to therapy, highlighting UBE2I as a potential target for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "28", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Donghai Lin, Michael H Tatham, Bin Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a substrate recognition site on Ubc9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M108418200"}], "href": "https://doi.org/10.1074/jbc.M108418200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11877416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11877416"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xia Lin, Min Liang, Yao-Yun Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C300112200"}], "href": "https://doi.org/10.1074/jbc.C300112200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12813045"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12813045"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "S Kobayashi, H Shibata, I Kurihara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Endocrinol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/jme.0.0320069"}], "href": "https://doi.org/10.1677/jme.0.0320069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14765993"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14765993"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yin-Yuan Mo, Yanni Yu, P L Rachel Ee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.can-03-2410"}], "href": "https://doi.org/10.1158/0008-5472.can-03-2410"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15087395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15087395"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Tomoko Komatsu, Hirofumi Mizusaki, Tokuo Mukai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2004-0173"}], "href": "https://doi.org/10.1210/me.2004-0173"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15192080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15192080"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Sara Salinas, Anne Briançon-Marjollet, Guillaume Bossis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200310136"}], "href": "https://doi.org/10.1083/jcb.200310136"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15210726"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15210726"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Michael H Tatham, Suhkmann Kim, Ellis Jaffray, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb878"}], "href": "https://doi.org/10.1038/nsmb878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15608651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15608651"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Isao Kurihara, Hirotaka Shibata, Sakiko Kobayashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubc9 and Protein Inhibitor of Activated STAT 1 Activate Chicken Ovalbumin Upstream Promoter-Transcription Factor I-mediated Human CYP11B2 Gene Transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M411820200"}], "href": "https://doi.org/10.1074/jbc.M411820200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15611122"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15611122"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Husheng Ding, Yingqi Xu, Quan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Solution structure of human SUMO-3 C47S and its binding surface for Ubc9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi0477586"}], "href": "https://doi.org/10.1021/bi0477586"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15723523"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15723523"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yin-Yuan Mo, Yanni Yu, Elena Theodosiou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A role for Ubc9 in tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208210"}], "href": "https://doi.org/10.1038/sj.onc.1208210"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15735760"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15735760"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Helen Rizos, Sarah Woodruff, Richard F Kefford "}, {"type": "b", "children": [{"type": "t", "text": "p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.4.4.1597"}], "href": "https://doi.org/10.4161/cc.4.4.1597"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15876874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15876874"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "David Reverter, Christopher D Lima "}, {"type": "b", "children": [{"type": "t", "text": "Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature03588"}], "href": "https://doi.org/10.1038/nature03588"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15931224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15931224"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Christoph Klenk, Jan Humrich, Ursula Quitterer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SUMO-1 controls the protein stability and the biological function of phosducin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M513703200"}], "href": "https://doi.org/10.1074/jbc.M513703200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16421094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16421094"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Zheng Fan, Yue Zhuo, Xinyu Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Virol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jmv.20707"}], "href": "https://doi.org/10.1002/jmv.20707"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16998888"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16998888"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Kenichi Yokota, Hirotaka Shibata, Isao Kurihara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M607741200"}], "href": "https://doi.org/10.1074/jbc.M607741200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17105732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17105732"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "S J Moschos, A P Smith, M Mandic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1210216"}], "href": "https://doi.org/10.1038/sj.onc.1210216"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17297476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17297476"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Mulu Geletu, Mumtaz Y Balkhi, Abdul A Peer Zada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-01-071035"}], "href": "https://doi.org/10.1182/blood-2007-01-071035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17671234"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17671234"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Alberto Carbia-Nagashima, Juan Gerez, Carolina Perez-Castro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2007.07.044"}], "href": "https://doi.org/10.1016/j.cell.2007.07.044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17956732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17956732"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jing Qu, Guang-Hui Liu, Kaiyuan Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nitric oxide destabilizes Pias3 and regulates sumoylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0001085"}], "href": "https://doi.org/10.1371/journal.pone.0001085"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17987106"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17987106"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Puck Knipscheer, Annette Flotho, Helene Klug, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubc9 sumoylation regulates SUMO target discrimination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2008.05.022"}], "href": "https://doi.org/10.1016/j.molcel.2008.05.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18691969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18691969"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Thomas Dünnebier, Justo Lorenzo Bermejo, Susanne Haas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.24286"}], "href": "https://doi.org/10.1002/ijc.24286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19358266"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19358266"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Firaz Mohideen, Allan D Capili, Parizad M Bilimoria, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A molecular basis for phosphorylation-dependent SUMO conjugation by the E2 UBC9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.1648"}], "href": "https://doi.org/10.1038/nsmb.1648"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19684601"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19684601"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "S Zhu, M Sachdeva, F Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2009.459"}], "href": "https://doi.org/10.1038/onc.2009.459"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20023705"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20023705"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Stergios J Moschos, Drazen M Jukic, Charalambos Athanassiou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2010.02.007"}], "href": "https://doi.org/10.1016/j.humpath.2010.02.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20561671"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20561671"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Ke Xu, Christoph Klenk, Bin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modification of nonstructural protein 1 of influenza A virus by SUMO1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.00877-10"}], "href": "https://doi.org/10.1128/JVI.00877-10"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21047957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21047957"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Hua Deng, Yingbo Lin, Margherita Badin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.12.038"}], "href": "https://doi.org/10.1016/j.bbrc.2010.12.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21147068"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21147068"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Gretchen L Bentz, Christopher B Whitehurst, Joseph S Pagano "}, {"type": "b", "children": [{"type": "t", "text": "Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.05035-11"}], "href": "https://doi.org/10.1128/JVI.05035-11"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21795333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21795333"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Khue Truong, Terry D Lee, Yuan Chen "}, {"type": "b", "children": [{"type": "t", "text": "Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.353789"}], "href": "https://doi.org/10.1074/jbc.M112.353789"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22403398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22403398"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "P Wimmer, P Blanchette, S Schreiner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.187"}], "href": "https://doi.org/10.1038/onc.2012.187"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22614022"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22614022"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Zhiqiang Zhao, Xiaochao Tan, Ani Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-214-mediated UBC9 expression in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMB Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5483/bmbrep.2012.45.11.097"}], "href": "https://doi.org/10.5483/bmbrep.2012.45.11.097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23187003"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23187003"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Hui Li, Huiyan Niu, Yang Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubc9 promotes invasion and metastasis of lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2268"}], "href": "https://doi.org/10.3892/or.2013.2268"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23381475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23381475"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Yung-Lin Hsieh, Hong-Yi Kuo, Che-Chang Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emboj.2013.5"}], "href": "https://doi.org/10.1038/emboj.2013.5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23395904"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23395904"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Sutirtha Datta, Chelsi J Snow, Bryce M Paschal "}, {"type": "b", "children": [{"type": "t", "text": "A pathway linking oxidative stress and the Ran GTPase system in progeria."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.E13-07-0430"}], "href": "https://doi.org/10.1091/mbc.E13-07-0430"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24523287"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24523287"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Bing Yu, Stephen Swatkoski, Alesia Holly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1415569112"}], "href": "https://doi.org/10.1073/pnas.1415569112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25805818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25805818"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "C H Lin, S Y Liu, E H Y Lee "}, {"type": "b", "children": [{"type": "t", "text": "SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2015.115"}], "href": "https://doi.org/10.1038/onc.2015.115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25867063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25867063"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Laurent Cappadocia, Andrea Pichler, Christopher D Lima "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for catalytic activation by the human ZNF451 SUMO E3 ligase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.3116"}], "href": "https://doi.org/10.1038/nsmb.3116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26524494"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26524494"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Eun Hee Koh, Yong Chen, David A Bader, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial Activity in Human White Adipocytes Is Regulated by the Ubiquitin Carrier Protein 9/microRNA-30a Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.749408"}], "href": "https://doi.org/10.1074/jbc.M116.749408"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27758866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27758866"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Domenico Mattoscio, Chiara Casadio, Claudia Miccolo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Autophagy regulates UBC9 levels during viral-mediated tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Pathog (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.ppat.1006262"}], "href": "https://doi.org/10.1371/journal.ppat.1006262"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28253371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28253371"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Ramesh Kumar, Román González-Prieto, Zhenyu Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-017-01900-x"}], "href": "https://doi.org/10.1038/s41467-017-01900-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29180619"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29180619"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Yunong Li, Xiuxing Jiang, Yanhao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear accumulation of UBC9 contributes to SUMOylation of lamin A/C and nucleophagy in response to DNA damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-019-1048-8"}], "href": "https://doi.org/10.1186/s13046-019-1048-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30744690"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30744690"}]}]}]}
Synonyms UBC9, C358B7.1
Proteins UBC9_HUMAN
NCBI Gene ID 7329
API
Download Associations
Predicted Functions View UBE2I's ARCHS4 Predicted Functions.
Co-expressed Genes View UBE2I's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View UBE2I's ARCHS4 Predicted Functions.

Functional Associations

UBE2I has 8,515 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 135 datasets.

Click the + buttons to view associations for UBE2I from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by UBE2I gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of UBE2I gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of UBE2I gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of UBE2I gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of UBE2I gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of UBE2I gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of UBE2I gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
Biocarta Pathways pathways involving UBE2I protein from the Biocarta Pathways dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of UBE2I gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of UBE2I gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of UBE2I gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of UBE2I gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of UBE2I gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of UBE2I gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with UBE2I protein from the CCLE Cell Line Proteomics dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of UBE2I gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of UBE2I gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of UBE2I gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI U2OS Cell Map Protein Localization Assemblies assemblies containing UBE2I protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of UBE2I gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing UBE2I protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing UBE2I protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing UBE2I protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing UBE2I protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with UBE2I protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with UBE2I protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
CORUM Protein Complexes protein complexs containing UBE2I protein from the CORUM Protein Complexes dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of UBE2I gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with UBE2I gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with UBE2I gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with UBE2I gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of UBE2I protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with UBE2I gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with UBE2I gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with UBE2I gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with UBE2I gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at UBE2I gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of UBE2I gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of UBE2I gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing UBE2I from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with UBE2I gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with UBE2I gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of UBE2I gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with UBE2I gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing UBE2I from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of UBE2I gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of UBE2I gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of UBE2I gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of UBE2I gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of UBE2I gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of UBE2I gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving UBE2I gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving UBE2I gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving UBE2I gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing UBE2I protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing UBE2I protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing UBE2I protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by UBE2I gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by UBE2I gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by UBE2I gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of UBE2I gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of UBE2I gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of UBE2I gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of UBE2I gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of UBE2I gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with UBE2I gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of UBE2I gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for UBE2I protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of UBE2I gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of UBE2I gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of UBE2I protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of UBE2I gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPM Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of UBE2I protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for UBE2I from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with UBE2I gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by UBE2I gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for UBE2I protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of UBE2I gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of UBE2I gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of UBE2I gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate UBE2I protein from the curated KEA Substrates of Kinases dataset.
KEGG Pathways 2026 pathways involving UBE2I protein from the KEGG Pathways 2026 dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate UBE2I protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of UBE2I gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of UBE2I gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with UBE2I gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of UBE2I gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of UBE2I gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of UBE2I gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of UBE2I gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing UBE2I protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain UBE2I protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by UBE2I gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting UBE2I gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of UBE2I gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by UBE2I gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for UBE2I from the MSigDB Cancer Gene Co-expression Modules dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of UBE2I gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing UBE2I protein recovered by IP-MS from the NURSA Protein Complexes dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for UBE2I from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of UBE2I gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of UBE2I gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving UBE2I protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving UBE2I protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with UBE2I protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate UBE2I protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
PID Pathways pathways involving UBE2I protein from the PID Pathways dataset.
ProteomicsDB Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of UBE2I protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset.
Reactome Pathways 2014 pathways involving UBE2I protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving UBE2I protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of UBE2I gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of UBE2I gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of UBE2I gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of UBE2I gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of UBE2I gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at UBE2I gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of UBE2I gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of UBE2I gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with UBE2I protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of UBE2I gene from the Sci-Plex Drug Perturbation Signatures dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with UBE2I gene from the SynGO Synaptic Gene Annotations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of UBE2I gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of UBE2I gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of UBE2I gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of UBE2I gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of UBE2I protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of UBE2I protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of UBE2I protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of UBE2I protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with UBE2I protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with UBE2I protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
Virus MINT Protein-Viral Protein Interactions interacting viral proteins for UBE2I from the Virus MINT Protein-Viral Protein Interactions dataset.
Virus MINT Protein-Virus Interactions viruses interacting with UBE2I from the Virus MINT Protein-Virus Interactions dataset.
WikiPathways Pathways 2014 pathways involving UBE2I protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving UBE2I protein from the WikiPathways Pathways 2024 dataset.